Overview

Eliglustat on Gaucher Disease Type IIIB

Status:
Unknown status

Trial end date:
2021-11-01

Target enrollment:

Participant gender:

Summary

Evaluation of the safety in the combination usage of Cerdelga and Cerezyme in type III Gaucher disease patients and the efficacy on soft tissue diseases.

Phase:

N/A

Details

Lead Sponsor:

National Taiwan University Hospital

Collaborator:

Sanofi

Treatments:

Eliglustat